MedPath

A pilot study to assess the feasibility of an integrated survivorship intervention to improve patient and service level outcomes for men with prostate cancer. ‘The True NTH Pilot Study’

Not Applicable
Completed
Conditions
Prostate cancer
Cancer - Prostate
Public Health - Health promotion/education
Registration Number
ACTRN12615000499583
Lead Sponsor
Professor Patsy Yates
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
51
Inclusion Criteria

Patients will be eligible for the study if they:
1) have been diagnosed with localised prostate cancer within the previous 3 months; OR
2) have been diagnosed with localised prostate cancer within the previous 12 months and are undergoing active surveillance or radiation treatment
3) are diagnosed with advanced prostate cancer, either having metastatic disease or biochemical recurrence progressing after salvage treatment or ineligible for salvage treatment
4) are able and willing to participate in the intervention and to complete patient reported outcome assessments.
5) Nominate a general practitioner who then agrees to use CDMnet.

Exclusion Criteria

Patients will be excluded from the study if they:
1)are too unwell (as determined by treating clinician)
2)have physical, psychological or cognitive difficulties that would prevent them from participating in the interventions or completing self report outcome measures.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath